OpGen
OPGN • NASDAQ
OpGen is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Christian-Laurent Benoit Bonte.
CEOChristian-Laurent Benoit Bonte
Medical - Diagnostics & Research
Healthcare
Employees100.0
Websiteopgen.com
Country
United States of America
Next Earnings
No upcoming earnings scheduled for OpGen
No earnings announcement scheduled
Earnings History
Past 12 earnings reports for OpGen
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Oct 1, 2025 | Q1 2025 | -$0.04 | — | - | — |  10-Q |
| Aug 21, 2025 | Q4 2024 | $0.16 | — | $5.0M | — | 10-K |
| Nov 15, 2024 | Q3 2024 | $1.35 | — | - | — | 10-Q |
| Aug 19, 2024 | Q2 2024 | -$1.18 | — | $28.0K | — | 10-Q/A |
| Jul 8, 2024 | Q1 2024 | $0.21 | — | $168.1K | — | 10-Q/A |
| Jun 3, 2024 | Q4 2023 | -$17.67Est: $0.00 | — | $1.1MEst: $1.1M | 0.0% | 10-K |
| Nov 14, 2023 | Q3 2023 | -$4.60Est: -$4.30 | -7.0% | $699.0KEst: $900.0K | -22.3% | — |
| Aug 10, 2023 | Q2 2023 | -$9.30Est: -$7.10 | -31.0% | $736.1KEst: $900.0K | -18.2% | 10-Q |
| May 15, 2023 | Q1 2023 | -$12.50Est: -$12.00 | -4.2% | $913.4KEst: $1.6M | -42.9% | — |
| Mar 29, 2023 | Q4 2022 | -$38.70Est: -$20.00 | -93.5% | $721.6KEst: $600.0K | +20.3% | — |
| Nov 10, 2022 | Q3 2022 | -$60.00Est: -$22.00 | -172.7% | $448.7KEst: $1.3M | -65.5% | — |
| Aug 11, 2022 | Q2 2022 | -$26.00Est: -$28.00 | +7.1% | $967.2KEst: $950.0K | +1.8% | — |